(Q34521884)

2 August 2017

title

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial (English)

1 reference

chronic obstructive pulmonary disease

2 August 2017

0 references

1 reference

1

Nicola A Hanania

1 reference

2 August 2017

Ted Lystig

5

1 reference

ORCID Public Data File 2021

Donald P Tashkin

7

object named as

Donald Tashkin

1 reference

2 August 2017

Amir Sharafkhaneh

2

1 reference

2 August 2017

Bartolome Celli

3

1 reference

2 August 2017

Marc Decramer

4

1 reference

2 August 2017

Steven Kesten

6

1 reference

2 August 2017

publication date

11 January 2011

1 reference

2 August 2017

1 reference

2 August 2017

volume

12

1 reference

2 August 2017

page(s)

6

1 reference

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Therapeutic responses in asthma and COPD. Bronchodilators

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Standardization of Spirometry, 1994 Update. American Thoracic Society

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Bronchodilator response in chronic obstructive pulmonary disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027109

Bronchodilator response in the lung health study over 11 yrs.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-6

Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-6

Bronchodilator responsiveness in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-6

Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-6

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-6

Criteria for the assessment of reversibility in airways obstruction. Report of the Committee on Emphysema American College of Chest Physicians

21 January 2018

1 reference

12 December 2020

Changes in measured spirometric indices. What is significant?

1 reference

12 December 2020

Bronchodilator testing: confidence intervals derived from placebo inhalations

1 reference

12 December 2020

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

12 December 2020

Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation

1 reference

12 December 2020

Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease

1 reference

12 December 2020

Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease

1 reference

12 December 2020

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

12 December 2020

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-12-6

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference